JMI White Paper now available through the World Anti-Microbial Congress

JMI provided a white paper, “Why Selecting the Appropriate Bacterial and Fungal Isolates in Your Drug Development Program Matters,” for the World Anti-Microbial Congress, held on October 8-9, 2020. The white paper was written by JMI Principal Scientist Leonard Duncan and CEO Andrew Fuhrmeister.

JMI White Paper now available through the World Anti-Microbial Congress

  • Details
  • Date:
  • October 7 - October 7
  • Event Website
  • Event Category:
  • Announcements
  • Venue
  • Online